Ocinaplon

DB06529ExperimentalSmall molecule

Investigated for use/treatment in anxiety disorders.

Chemical structure of Ocinaplon
Primary indication
Investigated for use/treatment in anxiety disorders.Curator reviewed
Formula / weight
C17H11N5O · 301.309 g/mol (avg)
Code names
CL-273547

Resolves to

Compound
UNII2H6KVC5E76CAS96604-21-6ChEMBLCHEMBL2105199
Structure
InChIKeyOQJFBUOFGHPMSR-UHFFFAOYSA-NSMILESO=C(C1=C2N=CC=C(N2N=C1)C1=CC=NC=C1)C1=CC=CC=N1
Targets
Q99928GABRG3

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
669Drug interactionsStructured to mechanism, not free text
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Ocinaplon, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In